Public-Private Partnerships On The Rise
Client Alert | less than 1 min read | 04.22.09
In "Funding America's Infrastructure Needs: Public-Private Partnerships May Help Close Infrastructure Gap," in the March 2009 issue of Construction Briefings, Steve McBrady of C&M examines the increasing use of Public-Private Partnerships (PPPs) in American infrastructure, as the federal government, states, and localities seek innovative mechanisms for upgrading and operating critical infrastructure. The recently passed American Recovery and Reinvestment Act of 2009, the Obama administration's proposal for a National Infrastructure Reinvestment Bank, and the upcoming Transportation Re-Authorization bill, will bolster these efforts and generate increased focus on the use of PPPs across the country.
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
